Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2015 Aug;67(8):1173–1179. doi: 10.1002/acr.22527

Table 2.

Report Age at
presentation
Age at
diagnosis
Genotype Other
abnormalities
Transaminase
elevation
Liver biopsy findings Extramedullary
hematopoeisis
Treatments Outcome
Hinson et al (1998) Perinatal 2 months ND None noted Yes (moderate) Chronic active cholestatic hepatitis Cutaneous unknown Hypotonia, FTT
Prenatal Unknown ND Hypospadias, frontal bossing, low-set ears, down-slanted palpebral fissues, long eyelashes Yes (moderate) Marked cholestatis, portal fibrosis Hepatic Unknown Died DOL 87
Raupp et al (2004) Prenatal Post- mortem ND None noted No ND No Antibiotics Died DOL 15
Prenatal DOL 20 L35S
homozygote
None noted No ND No Antibiotics Died 2 months
Steiner et al (2011) Prenatal Post- mortem I268T
homozygote
Ventriculomegaly, short limbs, frontal bossing, cardiomegaly unknown Marked fibrosis with bile plugging Cutaneous, lungs, liver, kidneys, adrenals Antibiotics Died DOL 20
Chaudhury et al (2012) Prenatal 2 weeks I268T
V310M
Aortic stenosis Unknown Micronodular cirrhosis No Anakinra, HSCT OLT age 4, normal growth and typically developing age 8

Clinical characteristics, liver findings and outcome of reported patient with MKD and cholestatic liver disease